APPENDIX 4.3(a) COMMERCIAL LICENSE REQUEST FORM (To be completed for each Commercial Target)

EX-10.3(B) 16 d344523dex103b.htm COMMERCIAL LICENSE REQUESTS UNDER THE SUBSCRIPTION AND LICENSE AGREEMENT Commercial License Requests under the Subscription and License Agreement

Exhibit 10.3(B)

Execution Version

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

APPENDIX 4.3(a)

COMMERCIAL LICENSE REQUEST FORM

(To be completed for each Commercial Target)

Target requested pursuant to Section 4.3 of the Subscription and License Agreement (define: by common name(s), accession number, and amino acid sequence, if possible):

[***]

Type of Commercial License Requested: Commercial Therapeutic License

 

ONCOMEDPHARMACEUTICALS, INC.     MORPHOSYS AG
By:  

/s/ John A. Lewicki

     By:  

/s/ I.A. Christine Rothe

Name:  

John A. Lewicki

     Name:  

Christine Rothe

Title:  

SR VP, R&D

     Title:  

Senior Manager, Alliance Manager

Date:  

28th April, 2008

     Date:  

6th May 2008

      MORPHOSYS AG
      By:  

/s/ Harald Watzka

      Name:  

Harald Watzka

      Title:  

Director, Head of AM

      Date:  

6th May 2008

[to be filled out by MORPHOSYS:] Does the Commercial License include a Clinical Monitoring License? (please circle) [***]

APPENDIX 4.3(a)

COMMERCIAL LICENSE REQUEST FORM

(To be completed for each Commercial Target)

Target requested pursuant to Section 4.3 of the Subscription and License Agreement (define: by common name(s), accession number, and amino acid sequence, if possible):

[***]

Type of Commercial License Requested: Commercial Therapeutic License

 

ONCOMEDPHARMACEUTICALS, INC.     MORPHOSYS AG
By:  

/s/ John A. Lewicki

     By:  

/s/ I.A. Christine Rothe

Name:  

John A. Lewicki

     Name:  

Christine Rothe

Title:  

SR VP, R&D

     Title:  

Senior Manager, Alliance Manager

Date:  

17th April, 2008

     Date:  

28th April 2008

      MORPHOSYS AG
      By:  

/s/ Harald Watzka

      Name:  

Harald Watzka

      Title:  

Director, Head of AM

      Date:  

28th April 2008

[to be filled out by MORPHOSYS:] Does the Commercial License include a Clinical Monitoring License? (please circle) [***]

 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.